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Abstract: 
The components of immune system are specific (adaptive immunity) and 
non-specific (innate immunity). Regardless of antigenic properties, the 
non-specific components function either as eliminators or barriers of wide 
range of pathogens. A person is born with innate immunity as the natural 
resistances, which has three kinds; anatomic mechanical and biochemical 
factors. The resistances are provided by innate immunity via various 
chemical, cellular and physical approaches. The colonization, entry and 
spread of microorganisms can be prevented by innate immunity. Two 
main sub-divided types of adaptive immunity are humeral and cellular. 
Active immunity resulting from the development of antibodies in 
response to the presence of an antigen is a long-term and acquired 
immunity. This review article summarizes some important potential 
mechanisms in innate immune system. The host renal tract which has 
been investigated from many aspects of the pathogenesis of urinary tract 
infection (UTI) are still poorly defined and require a better understanding 
of the pathophysiology immune system. 
Keywords: Adaptive immunity, Antibiotics, Children, Innate immunity, 
Urinary tract infection 
 
 
 
 
 
 
 
 
Introduction: 
Immunity has two non-specific (innate immunity) and specific (adaptive 
immunity) components 
[1-3]
. A person is born with innate immunity as the 
natural resistances. The resistances are provided by innate immunity via 
various chemical, cellular and physical approaches. The colonization, entry 
and spread of microorganisms can be prevented by innate immunity 
[1, 4]
. 
Two main sub-divided types of adaptive immunity are humeral and 
cellular. Naturally acquired immunity develops via non-deliberate contact 
with a disease causing agent, while artificially acquired immunity occurs 
just through deliberate measures like vaccination 
[5-8]
. Acquired passive 
immunity which is short lived can occur through transfer of activated T-
cells or antibodies from an immune host whereas active immunity is a 
form of long-term and acquired immunity resulting from the development 
of antibodies in response to the antigen presence 
[3, 4, 6, 9]
. The urinary tract 
is a sterile system under the normal circumstances. By age 6, 1%–2% of 
males and 3–7% of females suffer from a urinary tract infection (UTI). 
Long-term complications of UTI are scare, hypertension and chronic 
renal disease. Thus, it is necessary to find a greater understanding of UTI 
pathogenesis and how the body protects urinary tract and kidney from 
microbial pathogen 
[6, 10]
. 
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The nature of this human immune is unknown. The 
human defense mechanisms include numerous 
components of the immune system as well as genetic 
background and environmental exposures can change 
each component 
[6, 8]
.  
The aim of this study was to describe human 
defense mechanisms in children, to pay more attention 
to the studies whose quality is not adequate in the field 
of UTI in Iranian and global children and to focus on 
the need of research in this area. This review article 
focused on how the innate immune response keeps 
urinary tract sterility and discussed about the recent 
advances in the understanding of how this pathogen 
interacts with the host. 
 
Innate Immunity versus Adaptive 
Immunity in Urinary System 
Innate immune is composed of proteins and 
antimicrobial peptides (AMP) which speedily 
neutralize the chemokines, invader and cytokines that 
attract phagocytes to a threatened site as well as 
increase their microbicidal capacity and the phagocytes 
themselves 
[6, 11, 12]
. The bacteria may remain in the 
urinary tract system in spite of the innate immune 
response. Hence, a more specific adaptive immune 
response including cellular and humoral responses is 
resulted 
[1, 5, 6]
. 
Phagocytic cells as a first line of defense are 
belonged to polymorphonuclear leukocytes (PMNs; 
neutrophils) and derived from the bloodstream directly 
to the site of bacterial invasion 
[10]
. Uropathogenic 
Escherichia coli (UPEC) is the causative agent for 85–
95% of community suffered from UTI and 50% of all 
patients with nosocomial infection in hospital 
[3, 13]
. 
Most E.coli resulting in UTI pertain to O (Cell wall), K 
(capsular) and H (flagella) serotypes 
[14, 15]
.  
A recurrence of infection occurs in 10-30% of 
children with UTI, and most of these recurrences happen 
during 12 months of the primary infection 
[5, 11, 15]
. It may 
be that both bacterial factors and human host help the 
occurrence of UTI. Human immune system is 
categorized into acquired host factors and natural host 
defense factors. In the balance between infection of the 
urinary tract and sterility, host factors play a key role 
[12]
. 
Features likely to contribute to disease of the 
human immune system involve the responses to 
antigens (B- and T-cell features, PMNs), efficiency of 
bacterial destruction (e.g., lysozyme, complement) and 
types of antimicrobial substances produced (e.g, 
immunoglobulins, Cytokines) 
[16]
.  
Adhesion of bacteria to epithelia lining the urinary 
tract can be prevented by release of constitutive and 
inducible bactericidal antimicrobial peptides such as 
alpha- and beta-defensins and cathelicidin, lactoferrin, 
Tamm-Horsfall protein and lipocalin. Cytokines (IL-1 and 
TNF alpha) and chemokines (IL-8) activate and attract 
large numbers of macrophages and neutrophils which 
damage tubulointerstitial parenchyma with persistence of 
growing numbers of microorganisms 
[16-19]
. 
Biochemical and anatomical defense consists of 
paraurethral glandular secretion urine stream, IgA 
secretory, urine inhibitors (PH, Osmolality and Urea) 
and bladder emptying 
[16]
. Bacterial survival is 
decreased within the urinary tract via the presence of 
salts and urea, low pH, distance barrier of male urethra, 
other toxic metabolic end products, mucus in urine and 
hypertonic nature of kidney medulla 
[18]
. 
 
Mechanical Factors 
It seems that there are many mechanical forces to 
reduce UTIs, containing flushing mechanism and 
epithelial cell sloughing, urine flow and voiding, 
epithelial shedding as well as mucus shedding. A 
robust innate immune response is produced as 
uropathogenic E. coli prevails the mentioned physical 
barriers through adhering to the epithelium 
[10, 15]
. The 
papillary configuration is another factor which controls 
the renal susceptibility to scarring when the ducts of 
the papillae open to the calyces. A convex papilla has 
no reflux since the slitlike or crescentic openings of its 
collecting ducts obliquely open on the papilla, while a 
flat papilla or concave/compound papilla has reflux for 
the collecting ducts open at right angles onto a flat 
papilla 
[16, 17]
. 
 
Tamm-Horsfall glycoprotein (THP) 
Moreover, THP which is a glycoprotein 
(mucoprotein) and exists in urine is known as 
uromodulin or uromucoid and in humans is encoded by 
the UMOD gene 
[4]
. THP  is not produced from blood 
plasma whereas is generated from the epithelial cells in 
the thick ascending limb of the distal convoluted 
tubules, collecting ducts of mammalian kidney and 
loop of Henle 
[4, 11, 15]
. 
Although the role of THP is not well cleared, THP can 
really participate in transporter function and have a role in 
regulatory physiology. THP, itself, is not antimicrobial, 
stimulates the bacterial adherence and is the matrix of 
casts from the secretion of renal tubular 
[3, 19, 20]
. 
Antibodies to THP have been observed in different forms 
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of nephritis (e.g. Balkan nephropathy, Bence Jones 
proteinuria) 
[21-24]
. 
 
Defensins  
Defensins constrained by three sets of disulfide 
bonds are a group of highly structured compact 
peptides and highly cationic antimicrobial peptides 
produced by some variety of mammalian cells. The α 
and β classes are different based on the manner of 
folding. After exposure to pathogens, defensins which 
have the capacity to kill them are produced 
[9, 25]
. The 
α- and β-defensins which attract immature dendritic 
cells are categorized based on chromosome 8p23.1. 
The α-defensins, Human neutrophil peptides1 (HNP1) 
to HNP4, exist in high concentrations of neutrophils 
and supply the neutrophil with its microbicidal and 
nonoxidative activity. The β-defensins are extensively 
expressed through the epithelia 
[26-27]
. The strongest 
evidence is that in fact the defensins play the important 
role in the defense of the kidney of a genetically-
engineered mouse whose defensin gene which is 
similar to the constitutively expressed Human β-
defensin 1 peptide (HBD1) has been eliminated 
[27, 29]
. 
 
Lactoferrin 
Lactoferrin is a sub-fraction of whey protein, 
single-chain glycoprotein, the first line of defense for 
the body's immune system, present in the body’s 
secretions such as mucus, milk, blood, saliva and tears 
as well as binds easily with iron 
[18]
. Lactoferrin 
correlated with the luminal surface is expressed in the 
distal collecting tubules. A study has represented that 
the lactoferrin has beneficial effect on gut health and 
helps to prevent from viral and bacterial infections and 
cancers 
[30]
. 
 
Cathelicidin 
Cathelicidin as a linear peptide is expressed by 
circulating white cells on all epithelial surfaces. It is 
expressed along the human urinary tract 
[18, 31]
. 
Cathelicidin is a gene dependent on vitamin D, and 
vitamin D stores can affect susceptibility to UTI in 
selected individuals. Vitamin D supplementation may 
be effective to prevent from UTI 
[6, 12]
. 
 
Antimicrobial Peptides (AMPs) 
AMPs are extensively spread in the nature and have 
been found in specific fungi, bacteria, plants, protozoa 
and multicellular animals 
[6]
. Up to now, almost 1000 
various naturally occurring peptides have been 
detected. Generally, AMPs are tiny, between 20-60 
amino acids and positively charged due to the presence 
of amphipathic and lysine and/or arginine residues. All 
epithelial cells which come in contact with 
microorganisms produce AMPs 
[15, 31]
. 
 
Lipocalin 
Iron-trafficking protein removes or delivers iron 
from the cell. Lipocalin has multiple processes such as 
innate immunity, apoptosis and renal development. 
Lipocalin plays a role in innate immunity, possibly by 
sequestrating iron that limits bacterial growth 
[3]
. The 
certain stimuli, directly responsible for the induction of 
lipocalin, have not been known, yet. Lipocalin prepares 
a rapidly protective, antimicrobial and responsive 
function, limiting the invasion by uropathogens during 
the subsequent stages of recovery 
[32]
. 
 
P blood group secretor status 
P fimbrial attachment of bacteria to the urothelium 
only happens through glycolipid epithelial cell 
receptors which are members of the P blood group 
consisting of several antigens, Pk, P and P1. A 
decreased incidence of bacterial adherence to the 
urothelium can be found if the P blood group is 
secreted 
[33]
. 
 
Toll-Like Receptors (TLRs) 
TLR families are pathogen recognition and immune 
system. TLRs are the pattern recognition receptors 
expressed on epithelial cells and leucocytes, and 
recognize the preserved molecular motifs on pathogens 
and activation of the immune system 
[3]
. So far, thirteen 
human (TLR1-TLR13) and nine murine TLR proteins 
associated with the original Drosophila Toll gene have 
been discovered 
[18, 26]
. The activation of TLRs via 
different types of ligands induces the inflammatory 
chemokines and cytokines. For immune mobilization 
and UPEC recognition, TLRs 2, 4, 5 and 9 are very 
important. It has been indicated that the TLR2 responds 
to the components of Gram positive bacteria 
[34]
.  
The major lipopolysaccharide (LPS) sensor in 
mammals known as TLR4 is possibly recruited as part of 
the innate immune defense at this phase. TLR4 exists on 
the luminal surface of bladder epithelium 
[18, 35, 36]
 which 
generates cytokines, firstly via the stimulation of host 
TLR4 by bacterial LPS, that recruit PMNs to help to 
remove the bacteria 
[37]
. The production of cytokines 
generated through bladder epithelial cells is actively 
suppress the UPEC. Moreover, a safe haven for UPEC 
evasion from infiltrating PMNs is provided by the 
intracellular niche. The colonization with UPEC is 
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decreased by bactofection with TLR4 in the kidney and 
bladder by 91% and 41%, respectively 
[11, 38]
.  
 
Complement activation 
Complement is a system of interacting proteins as 
the heat-labile complementary principle and about 15% 
of the globulin fraction of serum. Age can affect the 
normal concentrations of serum complement 
components 
[39]
. The complement system as an 
essential component of innate immunity is widely 
conceived as the lectin, alternative and classical 
pathways which depend on and interact with each other 
for their full activity. The activation of each pathway 
results in formation of C3 and C5 convertases and the 
generation of biologically active components includes 
opsonins, membrane attack complex (MAC) and 
anaphylatoxins 
[40]
. 
 
Mannosylated uroplakin proteins 
Mannosylated uroplakin proteins serve as the 
receptors for invasion and binding to UPEC at the tips 
of type 1 pili by the FimH adhesin and coat the surface 
of the superficial umbrella cells of the bladder. The 
serious infection risk appears quite variable in humans. 
During bladder contraction, the reversible adjustments 
of the area of apical urothelial surface are influenced 
by the plaques retracted into the cytoplasm 
[41]
. Their 
reinsertion from unique cytoplasmic organelles named 
fusiform vesicles during bladder distention deliver 
preassembled crystalline arrays of uroplakin proteins to 
the surface of apical cell. Adhesion of bacteria to 
epithelia lining the urinary tract can be prevented by 
release of constitutive and inducible bactericidal 
antimicrobial peptides such as α- and β-defensins and 
cathelicidin, lactoferrin, Tamm-Horsfall protein and 
lipocalin. Microorganisms which overcome these early 
defenses activate an innate immune response and 
contact uroepithelia via TLR 
[1,12, 31]
. 
 
Bacterial factors 
Attachment 
Attachment between the bacteria and uroepithelial 
cell via factors such as type 1, P pili and fimbriae is 
considered as the initial and important event in 
infection. Voiding cannot delete the bacteria attached 
to the upper urinary tract. These adhesions mediate the 
interactions which can also stimulate a number of host 
responses that can directly affect the outcome of a UTI. 
Exfoliation of the superficial umbrella cells happens at 
the last stages of the acute infection in an attempt to 
omit the bacterial burden 
[4,19, 42]
. 
Invasion 
Intracellular bacterial communities are formed after 
the bacteria insert to the bladder epithelial cells and 
interact with uroplakins and lipid rafts 
[4]
. When these 
communities develop, they make cellular pods which 
protrude from the surface and might detach. 
Traditionally, UPEC has not been implicated as an 
intracellular pathogen. More lately, several adhesive 
organelles by UPEC with a few host factors have 
directly modulated and/or triggered the bacterial entry 
into the host cells. Especially, both Dr family adhesins 
and type 1 pili are considered as factors which are able 
to effectively progress the bacterial invasion of host 
cells through activating the distinct host cell signaling 
events.  
Fimbriae or pili have a critical role in sex and 
conjugation of organism and may enhance the 
uropathogenicity. Fimbriae are hair-like originate and 
very thin, and are found in the cytoplasm of the cell. 
Fimbriae project via the cell wall and membrane. 
Bacterial adherence to red blood and uroepithelial cells 
is mediated by the bacterial fimbriae. The Gal 1-4 Gal 
oligosaccharide fraction is considered as the specific 
receptor. Totally, 76-94% of pyelonephritogenic strains 
of E. coli compared with 19-23% of cystitis strains have 
P fimbriae 
[42]
. More than 80% of all UPEC produce type 
1 fimbriae (virulence factor) which are responsible for 
elevating the inflammatory response correlated to the 
bacterial invasion and adhesion in UTI 
[42]
. This family 
of adhesins is generally faced with the sever virulence 
factor 
[2, 43]
. 
 
Siderophores 
The organisms which apply the urinary tract as 
“fertile soil,” usually the gram-negative 
microorganisms' common to the distal bowel, need 
sufficient iron concentrations to support the growth. 
The organisms produce organic iron scavengers named 
siderophores which are empty as secreted and are 
pronely recovered as loaded with iron to remove their 
nutritional need of iron. Microorganisms resulting in 
UTIs have modified this iron-capture system in such a 
way that notify us of the antimicrobial defenses which 
are built around the iron economy 
[44, 45, 46]
  
Iron is a necessary nutrient for bacterial viability 
within the host, and the UPEC illustrates multiple 
mechanisms for iron extraction so that the most 
common of them is heme uptake and siderophore 
receptor systems. The siderophore systems are 
composed of aerobactin and entrobactin along with 
receptors including Iha, IreA and IroN 
[47]
.  
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Haemolysins 
Two common types of this toxin (haemolysin) are 
α-haemolysin and β-haemolysin. The former is a heat-
labile extracellular protein lyses erythrocytes and its 
production may be chromosomally characterized or 
plasmid. The latter (β-haemolysin) is a cell related to 
the haemolysin with a similar range of haemolytic 
activity just as α-haemolysin [48, 49]. 
 
Cytotoxic necrotizing factor (CNF) 
A subfamily of small GTP binding proteins is CNF 
types 1 and 2 which contribute to virulence and 
regulate the actin cytoskeleton. Membrane ruffling 
which forms the focal adhesions is shown by 
eukaryotic cells exposed to CNF1 
[50]
.  
 
Protectins 
The UPEC expresses a covering of polysaccharide 
capsule. The polysaccharide, especially LPS, plays a 
pivotal role in virulence 
[51]
. 
Normally, the urine is sterile and the defensive 
characteristics of uroepithelia aid to preserve this 
sterility as strategically need to survive for long-term. 
The serious infection risk appears quite variable in 
humans 
[19, 52, 53]
. 
Although there are numerous host defenses, most 
patients end up having recurrent UTI. New studies 
have suggested that the uropathogens may attack the 
surfaces of epithelial cells and replicate as well as this 
invasion can cause the superficial cells to exfoliate 
[51]
. 
A common bacterial infection is UTI in children 
[55]
. 
This infection is recurred in more than 30% of children 
with UTI, and most of these recurrences happen within 
12-18 months of the primary infection. The risk factors 
are genetic and other factors. Though there are many 
progresses in the interaction between host renal tract 
and pathogenic bacteria, numerous aspects of this 
interaction are still hardly understood 
[56]
. Proteomic 
and genomic studies of pathogens and host seem likely 
to be successful in future to discover the novel 
strategies for the host and pathogen interactions. 
 
 
Conclusion: 
There are some reasons for inability to eliminate the 
UTIs in children. Due to the anatomical location of the 
mea, it is interesting that the urine is normally sterile. 
A descending infection in the urinary tract can decline 
when bacteria can descend the urethra. At the same 
time, chemokines are released while leukocytes are 
recruited to the site of infection. Adhesion of bacteria 
to epithelia lining the urinary tract can be prevented by 
release of constitutive and inducible bactericidal 
antimicrobial peptides such as α- and β-defensins and 
cathelicidin, lactoferrin, Tamm-Horsfall protein and 
lipocalin. Cytokines (IL-1 and TNF alpha) and 
chemokines (IL-8) activate and attract large numbers of 
macrophages and neutrophils which damage 
tubulointerstitial parenchyma with persistence of 
growing numbers of microorganisms. 
Thus, comprehensive information regarding the 
associated features of the pathogen and host is very 
necessary for these proposed significant strategies to be 
completely effective. This review article summarizes 
some important potential mechanisms in innate 
immune system for better understanding of its 
pathophysiology. In spite of the long-term and repeated 
use of antimicrobial treatment, the common knowledge 
of the pathogenesis of UTI cannot describe the 
recurrence of infection, yet. 
 
 
Acknowledgments:  
The authors would like to thank all colleagues of 
Center for Pediatric Clinical Research and 
Development Hazrat Masoomeh Hospital, Qom. 
 
Author's contribution: Abbas Akhavan Sepahi 
and Rozita Hosseini conducted literature review and 
wrote the article. Mohsen Akhavan Sepahi planed, 
conducted and finalized the literature review. All 
authors read and signed the manuscript. 
 
Conflicts of interest: The authors declare no 
conflicts of interest.  
 
Ethical considerations: Ethical issues (including 
plagiarism, data fabrication, double publication) have 
been completely observed by the authors.  
 
Funding/Support: None. 
 
 
References: 
1. Becknell B, Schwaderer A, Hains DS, Spencer J D. 
Amplifying renal immunity: the role of antimicrobial 
peptides in pyelonephritis. Nat Rev Nephrol 2015; 
11(11): 642-55.doi:10.1038/nrneph.2015.105. 
2. Hains DS, Schwaderer AL. Genetic Variations in 
Vesicoureteral Reflux Sequelae. Pathogens 2016; 5(1): 
14. pii: E14. doi: 10.3390/pathogens5010014. 
  
287 | P a g e              Caspian Journal of Pediatrics, March 2018; Vol 4(No 1), Pp: 282-9 
3. Kucheria R, Dasgupta P, Sacks SH, et al. Urinary tract 
infections: new insights into a common problem. 
Postgrad Med J 2005; 81(952): 83-6. doi: 
10.1136/pgmj.2004.023036. 
4. Schillinga JD, Mulveya MA, Hultgrena SJ. Dynamic 
interactions between host and pathogen during acute 
urinary tract infections. Urol 2001; 57(6): 56-61. 
PMID: 11378051. 
5. Cheng CH, Lee YS, Chang CJ, et al. Genetic 
polymorphisms in inflammasome-dependent innate 
immunity among pediatric patients with severe renal 
parenchymal infections. PloS one 2015; 10(10): 
e0140128. doi: 10.1371/journal.pone.0140128. 
6. Lüthje P, Brauner A. Novel Strategies in the 
Prevention and Treatment of Urinary Tract Infections. 
Pathogens 2016; 5(1): 13. doi: 10.3390/pathogens 
5010013. 
7. Mak RH, Kuo HJ. Pathogenesis of urinary tract 
infection: an update. Curr Opin Pediatr 2006; 18(2): 
148-52. doi:10.1097/01.mop.0000193276.39495.0d. 
8. Ulett GC, Totsika M, Schaale K, et al. Uropathogenic 
Escherichia coli virulence and innate immune 
responses during urinary tract infection. Curr Opin 
Microbiol. 2013; 16(1): 100-7. doi: 
10.1016/j.mib.2013.01.005. Epub 2013 Feb 8 
9. Schwaderer AL, Wang H, Kim S, et al. Polymorphisms 
in α-Defensin-Encoding DEFA1A3 Associate with 
Urinary Tract Infection Risk in Children with 
Vesicoureteral Reflux. J Am Soc Nephrol 2016; 27 
(10): 3175-86. doi: 10.1681/ASN.2015060700. 
10. Rosen DA, Hooton TM, Stamm WE, et al. Detection of 
Intracellular Bacterial Communities in Human Urinary 
Tract Infection. PLoS Med 2007; 4(12): e329. doi: 
10.1371/journal.pmed.0040329. 
11. Liptáková A, Podracká L, Siegfried L. Urinary tract 
infections in children caused by uropathogenic strains 
of Escherichia coli and the role of the innate immune 
response mediated by the toll-like receptor 4 and 
antimicrobial peptide cathelicidin in their clinical 
course. Epidemiol Mikrobiol Imunol 2007; 56(2): 72-7. 
PMID: 17593804. 
12. Zasloff M. Antimicrobial peptides, innate immunity, 
and the normally sterile urinary tract. J Am Soc 
Nephrol 2007; 18(11): 2810-6. doi: 
10.1681/ASN.2007050611. Epub 2007 Oct 17. 
13. Akhavan Sepahi M, Heidari A, Shajari A. Clinicl 
manifestasions and etiology of renal stone in children 
less than 14 years age. Saudi J Kidney Dis Transpl 
2010; 21(1): 181-4. PMID: 20061721. 
14. Ejrnæs K. Bacterial characteristics of importance for 
recurrent urinary tract infections caused by Escherichia 
coli. Dan Med Bull 2011; 58(4): B4187, PMID: 
21466767. 
15. Svensson M, Yadav M, Holmqvist B, et al. Acute 
pyelonephritis and renal scarring are caused by 
dysfunctional innate immunity in mCxcr2 
heterozygous mice. Kidney Inter 2011; 80(10): 1064-
72. doi:10.1038/ki.2011.257. Epub 2011 Aug 3. 
16. Khoury AE, Bägli DJ, Vesicoureteral Reflux. In: 
McDougal WS, Wein AJ, Kavoussi LR, et al. 
Campbell-Walsh Urology, 11 ed. Elsevier; 2016. pp 
3134-55. 
17. Jayaweera JA, Reyes M. Antimicrobial misuse in 
pediatric urinary tract infections: recurrences and renal 
scarring. Ann Clin Microbiol Antimicrob 2018; 17(1): 
27. doi: 10.1186/s12941-018-0279-4. 
18. Mkaddem SB, Chassin C, Vandewalle A. Contribution 
of renal tubule epithelial cells in the innate immune 
response during renal bacterial infections and ischemia-
reperfusion injury. Chang Gung Med J 2010; 33(3): 
225-8. PMID: 20584500.  
19. Billips BK, Schaeffer AJ, Klumpp DJ. Molecular basis 
of uropathogenic Escherichia coli evasion of the innate 
immune response in the bladder. Infect Immun 2008; 
76(9): 3891-900. doi: 10.1128/IAI.00069-08. Epub 
2008 Jun 16. 
20. Song J, Abraham SN. Innate and adaptive immune 
responses in the urinary tract. Eur J Clin Invest. 2008; 
38 Suppl 2: 21-8. doi: 10.1111/j.1365-
2362.2008.02005.x.  
21. Bals R, Wang X, Zasloff M, Wilson JM. The peptide 
antibiotic LL-37/hCAP-18 is expressed in epithelia of 
the human lung where it has broad antimicrobial 
activity at the airway surface. Proc Natl Acad Sci U S 
A 1998; 95(16): 9541-6. PMID: 9689116. 
22. Loughman JA, Hunstad DA. Induction of indoleamine 
2, 3-dioxygenase by uropathogenic bacteria attenuates 
innate responses to epithelial infection. J Infect Dis 
2012; 205(12): 1830-9. doi: 10.1093/infdis/jis280. 
Epub 2012 Apr 3. 
23. Wu TH, Li KJ, Yu CL, Tsai CY. Tamm-Horsfall 
Protein is a potent immunomodulatory molecule and a 
disease biomarker in the urinary system. Molecules 
2018; 23(1): 200. doi: 10.3390/molecules23010200. 
Review.PMID: 29361765. 
24. Liu Y, Goldfarb DS, El-Achkar TM, Lieske JC, Wu 
XR. Tamm-Horsfall protein/uromodulin deficiency 
elicits tubular compensatory responses leading to 
hypertension and hyperuricemia. Am J Physiol Renal 
Physiol 2018; 314 (6): F1062-76. doi: 
10.1152/ajprenal.00233.2017. Epub 2018 Jan 10. 
  
288 | P a g e              Caspian Journal of Pediatrics, March 2018; Vol 4(No 1), Pp: 282-9 
25. Becknell B, Spencer JD, Carpenter AR, et al. 
Expression and antimicrobial function of beta-defensin 
1 in the lower urinary tract. PLoS One 2013; 8(10): 
e77714. doi: 10.1371/journal.pone.0077714. 
eCollection 2013. 
26. Hollox EJ, Armour JA, Barber JC. Extensive normal 
copy number variation of a β-defensin antimicrobial-
gene cluster. Am J Hum Genet 2003; 73(3): 591-600. 
Epub 2003 Aug 12. doi: 10.1086/378157. 
27. Lehmann J, Retz M, Harder J, et al. Expression of 
human beta-defensins 1 and 2 in kidneys with chronic 
bacterial infection. BMC Infect Dis 2002; 2(1): 20. 
PMID: 12238953PMCID: PMC128826. 
28. Schutte BC, Mitros JP, Bartlett JA, et al. Discovery of 
five conserved β-defensin gene clusters using a 
computational search strategy. Proc Natl Acad Sci 
2002; 99(4): 2129-33. doi:10.1073/pnas.042692699. 
29. Valore EV, Park CH, Quayle AJ, et al. Human beta-
defensin-1: an antimicrobial peptide of urogenital 
tissues. J Clin Invest 1998; 101(8): 1633-42. 
doi:10.1172/JCI1861. 
30. Ammons MC, Copié V. Mini-review: Lactoferrin: a 
bioinspired, anti-biofilm therapeutic. Biofouling 2013; 
29(4): 443-55. doi: 10.1080/08927014.2013.773317. 
31. Spencer JD, Schwaderer AL, Becknell B, et al. The 
innate immune response during urinary tract infection 
and pyelonephritis. Pediatr Nephrol 2014; 29(7): 1139-
49. doi: 10.1007/s00467-013-2513-9. Epub 2013 Jun 5. 
32. Moschen AR, Adolph TE, Gerner RR, et al. Lipocalin-
2: a master mediator of intestinal and metabolic 
inflammation. Trend Endocrinology Metabol 2017; 
28(5): 388-97. 
33. Bien J, Sokolova O, Bozko P. Role of uropathogenic 
Escherichia coli virulence factors in development of 
urinary tract infection and kidney damage. Inter J 
Nephrol 2012; 2012. Article ID 681473. 
34. Junpee A, Tencomnao T, Sanprasert V, Nuchprayoon 
S. Association between Toll-like receptor 2 (TLR2) 
polymorphisms and asymptomatic bancroftian 
filariasis. Parasitol Res 2010; 107(4): 807-16. doi: 
10.1007/s00436-010-1932-9.  
35. Cheng C-H, Lee Y-S, Chang C-J, Lin T-Y. Genetic 
polymorphisms in Toll-like receptors among pediatric 
patients with renal parenchymal infections of different 
clinical severities. PloS one 2013; 8(3): e58687, doi: 
10.1371/journal.pone.0058687. 
36. Sheinfeld J, Cordon-Cardo C, Fair WR, et al. 
Association of type 1 blood group antigens with 
urinary tract infections in children with genitourinary 
structural abnormalities. J Urol 1990; 144(2 Pt 2): 469-
73. 
37. Yin X, Chen L, Liu Y, et al. Enhancement of the innate 
immune response of bladder epithelial cells by 
Astragalus polysaccharides through upregulation of 
TLR4 expression. Biochem Biophys Res Commun 
2010; 397(2): 232-8. doi: 10.1016/j.bbrc.2010.05.090. 
38. Tabel Y, Berdeli A, Mir S. Association of TLR2 gene 
Arg753Gln polymorphism with urinary tract infection 
in children. Int J Immunogenet 2007; 34(6): 399-405. 
doi: 10.1111/j.1744-313X.2007.00709.x. 
39. Thurman JM, Renner B. Dynamic control of the 
complement system by modulated expression of 
regulatory proteins. Lab Invest 2011; 91(1):4-11. 
40. Sarma JV, Ward PA. The complement system. Cell 
Tissue Res 2011; 343(1): 227-35. 
41. Spaulding CN, Hultgren SJ. Adhesive pili in UTI 
pathogenesis and drug development. Pathogens 2016; 
5(1): 30. 
42. Gronbach K, Eberle U, Müller M, et al. Safety of 
probiotic Escherichia coli strain Nissle 1917 depends 
on intestinal microbiota and adaptive immunity of the 
host. Infect Immun 2010; 78(7): 3036-46. doi: 
10.1128/IAI.00218-10. Epub 2010 Apr 26. 
43. Selvarangan R, Goluszko P,  Singhal J, et al. 
Interaction of Dr Adhesin with collagen type iv is a 
critical step in Escherichia coli renal persistence. Infect 
Immun 2004; 72(8): 4827-35. doi: 
10.1128/IAI.72.8.4827-4835.2004. 
44. Trovero MF, Scavone P, Platero R, et al. 
Herbaspirillum seropedicae Differentially Expressed 
Genes in Response to Iron Availability. Front 
Microbiol 2018; 9: 1430. doi: 
10.3389/fmicb.2018.01430. eCollection 2018. PMID: 
3001860. 
45. Russo, T.A., U.B. Carlino, and J.R. Johnson, 
Identification of a new iron-regulated virulence gene, 
ireA, in an extraintestinal pathogenic isolate of 
Escherichia coli. Infect Immun, 2001. 69(10): p. 6209-
16. 
46. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. 
Bad bugs and beleaguered bladders: interplay between 
uropathogenic Escherichia coli and innate host 
defenses. Proceed National Academy of Sciences 2000; 
97(16): 8829-35. 
47. Lv H, Hung CS, Henderson JP. Metabolomic analysis 
of siderophore cheater mutants reveals metabolic costs 
of expression in uropathogenic Escherichia coli. J 
Proteome Res 2014; 13(3): 1397-404. 
48. Garcia TA, Ventura CL, Smith MA, et al. Cytotoxic 
necrotizing factor 1 and hemolysin from uropathogenic 
Escherichia coli elicit different host responses in the 
  
289 | P a g e              Caspian Journal of Pediatrics, March 2018; Vol 4(No 1), Pp: 282-9 
murine bladder. Infect Immun 2013; 81(1): 99-109, 
doi: 10.1128/IAI.00605-12. 
49. Svanborg C, Bergsten G, Fischer H, et al. 
Uropathogenic Escherichia coli as a model of host–
parasite interaction. Curr Opin Microbiol 2006; 9(1): 
33-9. doi:10.1016/j.mib.2005.12.012.PMID:16406777. 
50. Koyle MA, Elder JS, Skoog SJ, et al. Febrile urinary 
tract infection, vesicoureteral reflux, and renal scarring: 
current controversies in approach to evaluation. Pediatr 
Surg Int 2011; 27(4): 337-46. doi: 10.1007/s00383-
011-2863-y. Epub 2011 Feb 9. 
51. Bokil NJ, Totsika M, Carey AJ, et al. Intramacrophage 
survival of uropathogenic Escherichia coli: differences 
between diverse clinical isolates and between mouse 
and human macrophages. Immunobiol 2011; 216(11): 
1164-71. doi: 10.1016/j.imbio.2011.05.011. Epub 2011 
May 24. 
52. Hewitson TD. Renal tubulointerstitial fibrosis: 
common but never simple. Am J Physiol Renal Physiol 
2009; 296(6): F1239-44. doi: 
10.1152/ajprenal.90521.2008. Epub 2009 Jan 14. 
53. Johnson JR, Roberts PL, Stamm WE. P fimbriae and 
other virulence factors in Escherichia coli urosepsis: 
association with patients' characteristics. J Infect Dis. 
1987; 156(1): 225-9. PMID: 2885379. 
54. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A. Risk 
of renal scarring in children with a first urinary tract 
infection: a systematic review. Pediatrics. 2010; 
126(6): 1084-91. doi: 10.1542/peds.2010-0685. Epub 
2010 Nov 8. 
55. Sharifian M, Shohadaee S, Esfandiar N, et al. Serum 
and Urine Leptin concentrations in children before and 
after treatment of urinary tract infection. Iranian journal 
of kidney diseases. 2015; 9(5): 374-8. 
56. Sharifian M, Shiva MR, Akhavan Sepahi M, et al. 
Urinary ghrelin concentration in children with urinary 
tract infections before and after treatment. Arch Pediatr 
Infect Dis 2016; 4(2): 1-5. doi: 
10.5812/pedinfect.34096. 
 
